Skip to main content

Table 1 Characteristics of the study patient participants (n = 158)

From: Hand-held cardiac ultrasound examinations performed in primary care patients by nonexperts to identify reduced ejection fraction

Age, mean (SD), years69.9 (11.9)
Female sex71 (44.9%)
NT-proBNP, ng/L, median (IQR)195 (738)
Body mass index in kg/m2, mean (SD)28.2 (4.2)
Medical history, n/N (%)
 Chronic Heart failure, medication for34/158 (21.5%)
 Hypertension, medication for97/158 (61.4%)
 Diabetes mellitus, treatment for28/158 (17.7%)
 Dyslipidaemia, medication for55/158 (34.8%)
 Asthma or COPD24/158 (15.2%)
 Revascularisation21/158 (13.3%)
 AMI16/157 (10.2%)
 Stroke or TIA18/158 (11.4%)
Symptoms, n/N (%)
 Orthopnea23/157 (14.6%)
 Nocturnal dyspnoea30/158 (19.0%)
 Ankle oedema50/158 (31.6%)
Limitation of physical activity (NYHA I-IV), n/N (%)
 No limitation of physical activity65/156 (41.7%)
 Slight limitation of physical activity59/156 (37.8%)
 Marked limitation of physical activity29/156 (18.6%)
 Discomfort with any physical activity/
 symptoms occurring even at rest
3/156 (1.9%)
 Exertional chest pain, n/N (%)50/155 (32.3%)
  1. NT-proBNP N-terminal pro-B-type natriuretic peptide, COPD Chronic obstructive pulmonary disease, revascularisation = coronary bypass grafting or percutaneous coronary intervention; AMI Acute myocardial infarction, TIA Transitory ischaemic attack, NYHA New York Heart Association Functional Classification, SD Standard deviation, IQR Interquartile range